158 related articles for article (PubMed ID: 14727170)
1. Implantable venous port-related infections in cancer patients.
Huang WT; Chen TY; Su WC; Yen CJ; Tsao CJ
Support Care Cancer; 2004 Mar; 12(3):197-201. PubMed ID: 14727170
[TBL] [Abstract][Full Text] [Related]
2. Symptoms and signs of port-related infections in oncology patients related to the offending pathogens.
Liaw CC; Chen JS; Chang HK; Huang JS; Yang TS; Liau CT
Int J Clin Pract; 2008 Aug; 62(8):1193-8. PubMed ID: 18422589
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of device-associated infections related to a long-term implantable vascular access device.
Sotir MJ; Lewis C; Bisher EW; Ray SM; Soucie JM; Blumberg HM
Infect Control Hosp Epidemiol; 1999 Mar; 20(3):187-91. PubMed ID: 10100545
[TBL] [Abstract][Full Text] [Related]
4. Infectious morbidity associated with long-term use of venous access devices in patients with cancer.
Groeger JS; Lucas AB; Thaler HT; Friedlander-Klar H; Brown AE; Kiehn TE; Armstrong D
Ann Intern Med; 1993 Dec; 119(12):1168-74. PubMed ID: 8239247
[TBL] [Abstract][Full Text] [Related]
5. Outcome of totally implantable venous-access port-related infections.
Vidal M; Genillon JP; Forestier E; Trouiller S; Pereira B; Mrozek N; Aumeran C; Lesens O
Med Mal Infect; 2016 Feb; 46(1):32-8. PubMed ID: 26778362
[TBL] [Abstract][Full Text] [Related]
6. Port type is a possible risk factor for implantable venous access port-related bloodstream infections and no sign of local infection predicts the growth of gram-negative bacilli.
Hsu JF; Chang HL; Tsai MJ; Tsai YM; Lee YL; Chen PH; Fan WC; Su YC; Yang CJ
World J Surg Oncol; 2015 Sep; 13():288. PubMed ID: 26420628
[TBL] [Abstract][Full Text] [Related]
7. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
[TBL] [Abstract][Full Text] [Related]
8. Central venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse.
Hanna H; Afif C; Alakech B; Boktour M; Tarrand J; Hachem R; Raad I
Infect Control Hosp Epidemiol; 2004 Aug; 25(8):646-9. PubMed ID: 15357155
[TBL] [Abstract][Full Text] [Related]
9. Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.
Narducci F; Jean-Laurent M; Boulanger L; El Bédoui S; Mallet Y; Houpeau JL; Hamdani A; Penel N; Fournier C
Eur J Surg Oncol; 2011 Oct; 37(10):913-8. PubMed ID: 21831566
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for the development of central line-associated bloodstream infection due to gram-negative bacteria in intensive care unit patients after surgery.
Sreeramoju PV; Tolentino J; Garcia-Houchins S; Weber SG
Infect Control Hosp Epidemiol; 2008 Jan; 29(1):51-6. PubMed ID: 18171187
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of infectious complications of the implantable venous access system in a general oncologic population.
Chang L; Tsai JS; Huang SJ; Shih CC
Am J Infect Control; 2003 Feb; 31(1):34-9. PubMed ID: 12548255
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous bacterial colonization, modalities of chemotherapeutic infusion, and catheter-related bloodstream infection in totally implanted venous access devices.
Laurenzi L; Natoli S; Benedetti C; Marcelli ME; Tirelli W; DiEmidio L; Arcuri E
Support Care Cancer; 2004 Nov; 12(11):805-9. PubMed ID: 15372220
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for the management of intravascular catheter-related infections.
Mermel LA; Farr BM; Sherertz RJ; Raad II; O'Grady N; Harris JS; Craven DE;
J Intraven Nurs; 2001; 24(3):180-205. PubMed ID: 11530364
[TBL] [Abstract][Full Text] [Related]
14. Port-related Aeromonas bacteremia.
Chen CM; Lai CC; Chao CM
Infect Control Hosp Epidemiol; 2014 Sep; 35(9):1204-6. PubMed ID: 25111938
[No Abstract] [Full Text] [Related]
15. Catheter-associated bloodstream infections in pediatric hematology-oncology patients: factors associated with catheter removal and recurrence.
Adler A; Yaniv I; Solter E; Freud E; Samra Z; Stein J; Fisher S; Levy I
J Pediatr Hematol Oncol; 2006 Jan; 28(1):23-8. PubMed ID: 16394888
[TBL] [Abstract][Full Text] [Related]
16. How long does it take to "rule out" bacteremia in children with central venous catheters?
Shah SS; Downes KJ; Elliott MR; Bell LM; McGowan KL; Metlay JP
Pediatrics; 2008 Jan; 121(1):135-41. PubMed ID: 18166567
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of Gram staining of peri-catheter skin and the connection in the prediction of intravascular-catheter-related bacteremia].
León M; García M; Herranz MA; González V; Martínez A; Castillo F; Andrés E; León C; Huet J
Enferm Infecc Microbiol Clin; 1998 May; 16(5):214-8. PubMed ID: 9666583
[TBL] [Abstract][Full Text] [Related]
18. Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes?
Sexton DJ; Chen LF; Anderson DJ
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1286-9. PubMed ID: 20979492
[No Abstract] [Full Text] [Related]
19. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC
Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304
[TBL] [Abstract][Full Text] [Related]
20. Commentary: zero tolerance for catheter-related bloodstream infections: the unnegotiable objective.
Raad II
Infect Control Hosp Epidemiol; 2008 Oct; 29(10):951-3. PubMed ID: 18754737
[No Abstract] [Full Text] [Related]
[Next] [New Search]
